— Know what they know.
Not Investment Advice
Also trades as: ABVX.PA (PAR) · $vol 25M · 0RA9.L (LSE) · $vol 1M · AAVXF (OTC) · $vol 0M

ABVX NASDAQ

Abivax S.A.
1W: -6.0% 1M: -10.2% 3M: -26.8% YTD: -35.0% 1Y: -4.1% 3Y: +948.2%
$87.00
+0.50 (+0.58%)
 
Weekly Expected Move ±7.2%
$75 $82 $88 $94 $101
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 34 · $7.6B mcap · 79M float · 1.75% daily turnover · Short 37% of daily vol
Credit Risk of going bust: lower than 81% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down more than 99.9%), Abivax S.A. would be worth roughly what it owes.
Total debt $1.3M against a stock market value of $7.62B.
Distance to default 9.87 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $674K (short-term plus half of long-term), stock volatility 90.8%; Altman Z'' -2.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$118
Low
$134
Avg Target
$151
High
Based on 2 analysts since Sep 21, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 12Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$141.33
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-22 Wedbush — $90 $118 +28 +14.1% $103.45
2026-09-22 Truist Financial — $155 $151 -4 +46.0% $103.45
2026-09-09 Goldman Sachs — Initiated $155 — +29.8% $119.46
2026-07-24 Morgan Stanley — $132 $180 +48 +39.9% $128.63
2026-07-09 Piper Sandler — $142 $175 +33 +26.3% $138.54
2026-07-02 Truist Financial — $135 $155 +20 +16.9% $132.56
2026-06-30 Jefferies Faisal Khurshid $90 $158 +68 +18.6% $133.26
2026-06-30 BTIG Julian Harrison $150 $175 +25 +82.0% $96.15
2026-06-03 Wolfe Research — $176 $136 -40 +51.6% $89.72
2026-06-02 Truist Financial — $140 $135 -5 +73.5% $77.82
2026-06-02 Morgan Stanley Judah Frommer $145 $132 -13 +1.8% $129.69
2026-06-02 Wedbush — $110 $90 -20 -30.6% $129.69
2026-06-02 Jefferies Faisal Khurshid Initiated $90 — -30.6% $129.69
2026-02-24 Wedbush David Nierengarten Initiated $110 — -17.2% $132.91
2026-01-09 Morgan Stanley — $12 $145 +133 +24.0% $116.97
2026-01-08 BTIG Julian Harrison $120 $150 +30 +18.6% $126.48
2026-01-08 Oppenheimer — Initiated $131 — +3.6% $126.48
2025-12-18 Guggenheim Yatin Suneja $150 $175 +25 +49.3% $117.23
2025-12-16 Piper Sandler — $42 $142 +100 +28.0% $110.98
2025-11-24 Truist Financial Gregory Renza Initiated $140 — +17.5% $119.12
2025-11-05 Wolfe Research — Initiated $176 — +76.7% $99.61
2025-10-13 Barclays Etzer Darout Initiated $142 — +51.4% $93.77
2025-10-10 Guggenheim — Initiated $150 — +65.5% $90.61
2025-10-06 BTIG — $43 $120 +77 +38.5% $86.67
2025-09-25 JMP Securities — $33 $114 +81 +39.0% $82.00
2025-07-23 Leerink Partners Thomas Smith Initiated $74 — +16.1% $63.74
2025-07-18 JMP Securities Jason Butler Initiated $33 — +219.1% $10.34
2025-03-20 Morgan Stanley — Initiated $12 — +70.0% $7.06
2024-09-10 Piper Sandler Alexander Potter Initiated $42 — +250.3% $11.99
2024-05-20 BTIG Julian Harrison Initiated $43 — +215.2% $13.64

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 27, 2026
DCF
2
ROE
1
ROA
1
D/E
4
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ABVX receives an overall rating of C. Strongest factors: D/E (4/5). Areas of concern: DCF (2/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-12 C- C
2026-10-01 C C-
2026-05-14 C- C
2026-04-01 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
36
Earnings Quality
30
Growth
12
Value
—
Momentum
20
Safety
—
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
4/9
✗ ✗ ✓ ✓ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
-4.38
Bankruptcy prob: 1.2%
Low Risk
Credit Rating
BB+
Score: 49.4/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.30x
Accruals: -96.9%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ABVX scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ABVX's implied 1.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ABVX receives an estimated rating of BB+ (score: 49.4/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-16.95x
PEG
0.31x
P/S
-3465.64x
P/B
17.36x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ABVX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.999
NI / EBT
×
Interest Burden
1.068
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
1.830
Assets / Equity
=
ROE
-254.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ABVX's ROE of -254.8% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 757 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$87.00
Median 1Y
$82.06
5th Pctile
$9.85
95th Pctile
$679.64
Ann. Volatility
130.5%
Analyst Target
$141.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
69
0.0% YoY
Revenue / Employee
—
Profit / Employee
$-4,678,797
NI: $-322,836,959
SGA / Employee
$999,399
Avg labor cost proxy
R&D / Employee
$2,474,569
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
ROE -48.9% -1.1% -1.1% -5.0% -1.6% -2.5% -2.55%
ROA -29.3% -48.0% -50.9% -96.7% -98.4% -1.4% -1.39%
ROIC 10.5% -6.0% 21.8% 7.3% 5.4% 5.2% 5.19%
ROCE -38.6% -64.7% -1.2% -25.6% -67.3% -97.2% -97.22%
Gross Margin 1.0% 1.0% 1.0% 1.0% — — —
Operating Margin -39.8% -11.8% -18.0% -46.5% — — —
Net Margin -41.2% -12.0% -12.8% -50.0% — — —
EBITDA Margin -39.6% -11.8% -17.8% -46.4% — — —
FCF Margin -30.6% -19.9% -10.4% -14.4% -68.4% — —
OCF Margin -30.6% -19.9% -10.3% -14.4% -68.4% — —
ROA 3Y Avg snapshot only -99.66%
ROIC Economic snapshot only -60.98%
Cash ROA snapshot only -26.67%
Valuation
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
P/E Ratio — — — — — — -16.953
P/S Ratio — — — — — — -3465.636
P/B Ratio — — — — — — 17.364
P/FCF — — — — — — —
P/OCF — — — — — — —
EV/EBITDA — — — — — — —
EV/Revenue — — — — — — —
EV/EBIT — — — — — — —
EV/FCF — — — — — — —
Earnings Yield — — — — — — —
FCF Yield — — — — — — —
PEG Ratio snapshot only 0.307
Leverage & Solvency
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Current Ratio 3.25 3.04 1.84 0.77 8.75 5.97 5.965
Quick Ratio 3.25 3.04 1.84 0.77 8.75 5.97 5.965
Debt/Equity 0.30 0.90 2.40 -1.75 0.07 0.00 0.003
Net Debt/Equity -1.04 -0.86 -1.15 — -1.09 -1.12 -1.118
Debt/Assets 0.18 0.40 0.47 0.71 0.05 0.00 0.003
Debt/EBITDA -0.63 -0.86 -0.57 -0.37 -0.09 -0.00 -0.003
Net Debt/EBITDA 2.20 0.83 0.27 -0.10 1.42 1.08 1.082
Interest Coverage -16.20 -20.61 -63.55 -22.28 -15.73 -23.72 -23.723
Equity Multiplier 1.67 2.25 5.06 -2.48 1.28 1.26 1.262
Cash Ratio snapshot only 5.729
Debt Service Coverage snapshot only -23.648
Cash to Debt snapshot only 338.848
FCF to Debt snapshot only -101.796
Defensive Interval snapshot only 544.4 days
Efficiency & Turnover
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Asset Turnover 0.01 0.02 0.04 0.05 0.01 0.00 0.000
Inventory Turnover — — — — — — —
Receivables Turnover 0.12 — 0.62 1.28 0.15 0.00 0.000
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 —
DSO 2988 0 587 286 2366 — —
DIO — — — — — — —
DPO — — — — — — —
Cash Conversion Cycle — — — — — — —
Fixed Asset Turnover snapshot only 0.000
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue — — 3.6% 64.6% -81.3% -1.0% -1.00%
Net Income — — -41.4% -43.0% -1.9% -1.1% -1.07%
EPS — — -8.1% -41.9% -1.6% -65.1% -65.07%
FCF — — -57.1% -19.3% -23.2% 9.3% 9.27%
EBITDA — — -86.7% -70.9% -1.0% -67.8% -67.78%
Op. Income — — -87.1% -71.1% -69.5% -25.1% -25.14%
OCF Growth snapshot only 9.03%
Asset Growth snapshot only 2.86%
Debt Growth snapshot only -98.57%
Shares Change snapshot only 25.61%
Growth Quality
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue Stability — — — — 0.00 0.36 0.363
Earnings Stability — — — — 0.85 0.90 0.905
Margin Stability — — — — 1.00 — —
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0
Earnings Persistence — — — — 0.50 0.50 0.500
Earnings Smoothness — — — — — — —
ROE Trend — — — — 1.06 — —
Gross Margin Trend — — — — 0.00 — —
FCF Margin Trend — — — — -47.89 — —
Sustainable Growth Rate — — — — — — —
Internal Growth Rate — — — — — — —
Cash Flow Quality
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
OCF/Net Income 0.74 0.83 0.82 0.69 0.35 0.30 0.304
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.001
FCF/Net Income snapshot only 0.305
CapEx/Revenue 5.0% 4.1% 3.0% 2.8% 2.7% — —
CapEx/Depreciation snapshot only 0.087
Accruals Ratio -0.08 -0.08 -0.09 -0.30 -0.63 -0.97 -0.969
Sloan Accruals snapshot only 1.310
Cash Flow Adequacy snapshot only -1185.317
Dividends & Buybacks
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Dividend Yield — — — — — — 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — —
FCF Payout Ratio — — — — — — —
Total Payout Ratio — — — — — — —
Div. Increase Streak — — — — — — —
Chowder Number — — — — — — —
Buyback Yield — — — — — — —
Net Buyback Yield — — — — — — —
Total Shareholder Return — — — — — — —
DuPont Factors
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Tax Burden (NI/EBT) 0.98 0.98 1.00 1.00 1.02 1.00 0.999
Interest Burden (EBT/EBIT) 1.06 1.05 1.02 1.05 1.09 1.07 1.068
EBIT Margin -39.70 -23.14 -12.32 -19.83 -173.81 — —
Asset Turnover 0.01 0.02 0.04 0.05 0.01 0.00 0.000
Equity Multiplier 1.67 2.25 2.25 5.17 1.59 1.83 1.830
Per Share
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
EPS (Diluted TTM) $-1.98 $-2.17 $-2.14 $-3.08 $-5.59 $-5.09 $-5.09
Book Value/Share $4.06 $2.01 $0.64 $-0.76 $6.54 $4.60 $4.60
Tangible Book/Share $3.54 $1.61 $0.25 $-1.16 $6.18 $4.28 $4.28
Revenue/Share $0.05 $0.09 $0.17 $0.15 $0.03 $0.00 $-0.03
FCF/Share $-1.48 $-1.81 $-1.77 $-2.14 $-1.98 $-1.55 $-1.85
OCF/Share $-1.47 $-1.81 $-1.76 $-2.14 $-1.98 $-1.55 $-1.85
Cash/Share $5.40 $3.53 $2.28 $0.96 $7.63 $5.16 $5.16
EBITDA/Share $-1.91 $-2.10 $-2.72 $-3.56 $-5.03 $-4.75 $-4.75
Debt/Share $1.20 $1.80 $1.54 $1.33 $0.46 $0.02 $0.02
Net Debt/Share $-4.20 $-1.73 $-0.74 $0.37 $-7.16 $-5.14 $-5.14
Academic Models
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Altman Z-Score — — — — — — —
Piotroski F-Score 2 2 2 2 3 4 4
Beneish M-Score — — -1.72 -5.32 — — —
Ohlson O-Score snapshot only -4.382
ROIC (Greenblatt) snapshot only -1.06%
Net-Net WC snapshot only $4.16
Credit
Metric Trend Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Credit Rating snapshot only BB+
Credit Score 49.06 47.42 38.77 20.00 49.60 49.38 49.381
Credit Grade snapshot only 11
Credit Trend snapshot only 1.964
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 47
Sector Credit Rank snapshot only 42

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms